Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology
| dc.contributor.author | Grazia, Giuseppe Di | |
| dc.contributor.author | Schettini, Francesco | |
| dc.contributor.author | Sánchez Bayona, Rodrigo | |
| dc.contributor.author | Casals Pascual, Climent | |
| dc.contributor.author | Pascual, Tomás | |
| dc.contributor.author | Generali, Daniele | |
| dc.contributor.author | Gennari, Alessandra | |
| dc.contributor.author | Vigneri, Paolo | |
| dc.contributor.author | Harbeck, Nadia | |
| dc.contributor.author | Cortés, Javier | |
| dc.contributor.author | Prat Aparicio, Aleix | |
| dc.date.accessioned | 2026-04-29T17:29:52Z | |
| dc.date.available | 2026-04-29T17:29:52Z | |
| dc.date.issued | 2026-01-28 | |
| dc.date.updated | 2026-04-29T17:29:53Z | |
| dc.description.abstract | Hormone receptor-positive/HER2-negative breast cancer evolves in response to therapy, demanding smarter, adaptive biomarker-based treatment strategies. We review emerging dynamic biomarkers to guide therapeutic decision-making, spanning tissue and liquid biopsies, metabolic imaging, and microbiome profiling, that capture tumor or host-related changes over time. By contrasting Academic and Industry approaches, we advocate for a cultural shift in clinical trial design and implementation, aiming to move from reactive to proactive Oncology. | |
| dc.format.extent | 9 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 769784 | |
| dc.identifier.issn | 2374-4677 | |
| dc.identifier.pmid | 41605941 | |
| dc.identifier.uri | https://hdl.handle.net/2445/229253 | |
| dc.language.iso | eng | |
| dc.publisher | Springer Nature | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1038/s41523-026-00904-5 | |
| dc.relation.ispartof | npj Breast Cancer, 2026, vol. 12, 34 | |
| dc.relation.uri | https://doi.org/10.1038/s41523-026-00904-5 | |
| dc.rights | cc-by (c) Giuseppe Di Grazia et al., 2026 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | Articles publicats en revistes (Fonaments Clínics) | |
| dc.subject.classification | Assaigs clínics de medicaments | |
| dc.subject.classification | Càncer de mama | |
| dc.subject.classification | Hormonoteràpia | |
| dc.subject.other | Drug testing | |
| dc.subject.other | Breast cancer | |
| dc.subject.other | Hormone therapy | |
| dc.title | Dynamic biomarkers in hormone receptor-positive/HER2-negative breast cancer trials: a new hope for precision oncology | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1